New CSO at Sanofi
This article was originally published in Scrip
Sanofi has appointed Dr David-Alexandre Gros chief strategy officer, reporting to Sanofi's CEO Christopher Viehbacher, effective 1 September. Dr Gros joins Sanofi from the Healthcare Investment Banking division of Centreview Partners, where he was a principal and founder, serving as an advisor to pharmaceutical, biotechnology and diagnostic companies.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.